$HXL
HEXCEL CORP /DE/

2024 Q2 Form 10-Q Financial Statement

#000095017024046457 Filed on April 22, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $500.4M $472.3M $457.7M
YoY Change 10.15% 3.19% 17.18%
Cost Of Revenue $373.8M $354.1M $330.0M
YoY Change 8.82% 7.3% 8.59%
Gross Profit $126.6M $118.2M $127.7M
YoY Change 14.26% -7.44% 47.29%
Gross Profit Margin 25.3% 25.03% 27.9%
Selling, General & Admin $39.90M $49.00M $50.80M
YoY Change 11.76% -3.54% 13.65%
% of Gross Profit 31.52% 41.46% 39.78%
Research & Development $14.70M $15.10M $13.90M
YoY Change 10.53% 8.63% 27.52%
% of Gross Profit 11.61% 12.77% 10.88%
Depreciation & Amortization $31.00M $31.00M $30.70M
YoY Change 0.0% 0.98% -4.66%
% of Gross Profit 24.49% 26.23% 24.04%
Operating Expenses $54.60M $64.10M $64.70M
YoY Change 11.43% -0.93% 16.37%
Operating Profit $71.80M $54.10M $62.80M
YoY Change 16.18% -13.85% 108.64%
Interest Expense $8.100M -$6.500M $9.400M
YoY Change -188.04% -169.15% 3.3%
% of Operating Profit 11.28% -12.01% 14.97%
Other Income/Expense, Net
YoY Change
Pretax Income $63.70M $46.40M $53.40M
YoY Change 22.26% -13.11% 154.29%
Income Tax $13.70M $9.900M $11.70M
% Of Pretax Income 21.51% 21.34% 21.91%
Net Earnings $50.00M $36.50M $42.70M
YoY Change 17.65% -14.52% 139.89%
Net Earnings / Revenue 9.99% 7.73% 9.33%
Basic Earnings Per Share
Diluted Earnings Per Share $0.60 $0.43 $0.50
COMMON SHARES
Basic Shares Outstanding 83.11M 84.39M 84.28M
Diluted Shares Outstanding 83.20M 84.80M 85.50M

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $75.40M $85.90M $105.7M
YoY Change -27.64% -18.73% -6.29%
Cash & Equivalents $75.40M $85.90M $105.7M
Short-Term Investments
Other Short-Term Assets $63.10M $47.80M $53.70M
YoY Change 4.3% -10.99% -12.11%
Inventory $351.5M $353.8M $354.6M
Prepaid Expenses
Receivables $283.1M $302.2M $265.3M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $807.6M $789.7M $807.9M
YoY Change -0.31% -2.25% 18.05%
LONG-TERM ASSETS
Property, Plant & Equipment $1.649B $1.658B $1.651B
YoY Change -1.87% 0.45% -3.57%
Goodwill $187.6M $187.8M $187.7M
YoY Change -0.37% 0.05% -0.79%
Intangibles $59.20M $60.90M $67.50M
YoY Change -10.17% -9.78% -9.76%
Long-Term Investments $5.000M $5.000M $52.70M
YoY Change -90.02% -90.51% 15.57%
Other Assets $119.5M $119.6M $140.8M
YoY Change -6.13% -15.06% -4.67%
Total Long-Term Assets $2.020B $2.032B $2.099B
YoY Change -4.35% -3.23% -3.21%
TOTAL ASSETS
Total Short-Term Assets $807.6M $789.7M $807.9M
Total Long-Term Assets $2.020B $2.032B $2.099B
Total Assets $2.828B $2.821B $2.907B
YoY Change -3.23% -2.96% 1.89%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $124.8M $128.1M $122.0M
YoY Change 6.21% 5.0% 8.44%
Accrued Expenses $85.40M $155.9M $91.90M
YoY Change -41.02% 69.64% 24.53%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $100.0K $100.0K $200.0K
YoY Change 0.0% -50.0% -71.43%
Total Short-Term Liabilities $293.7M $288.6M $290.1M
YoY Change 6.37% -0.52% 17.4%
LONG-TERM LIABILITIES
Long-Term Debt $794.9M $714.6M $768.5M
YoY Change 2.04% -7.01% -10.38%
Other Long-Term Liabilities $30.20M $77.50M $58.30M
YoY Change -63.7% 32.93% -21.11%
Total Long-Term Liabilities $825.1M $792.1M $826.8M
YoY Change -4.3% -4.2% -11.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $293.7M $288.6M $290.1M
Total Long-Term Liabilities $825.1M $792.1M $826.8M
Total Liabilities $1.256B $1.189B $1.285B
YoY Change 0.05% -7.47% -5.95%
SHAREHOLDERS EQUITY
Retained Earnings $2.230B $2.193B $2.137B
YoY Change 2.81% 2.59% 5.71%
Common Stock $960.7M $955.7M $921.9M
YoY Change 3.64% 3.67% 3.47%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.528B $1.427B $1.285B
YoY Change 18.95% 11.08% 0.25%
Treasury Stock Shares $26.20M
Shareholders Equity $1.571B $1.632B $1.622B
YoY Change
Total Liabilities & Shareholders Equity $2.828B $2.821B $2.907B
YoY Change -3.23% -2.96% 1.89%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income $50.00M $36.50M $42.70M
YoY Change 17.65% -14.52% 139.89%
Depreciation, Depletion And Amortization $31.00M $31.00M $30.70M
YoY Change 0.0% 0.98% -4.66%
Cash From Operating Activities $44.20M -$7.000M -$23.40M
YoY Change -17.38% -70.09% 23.16%
INVESTING ACTIVITIES
Capital Expenditures $22.90M $28.70M $18.10M
YoY Change -59.61% 58.56% -13.4%
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities -$22.90M -$28.70M -$18.10M
YoY Change -57.75% 58.56% -13.4%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -31.70M -104.3M 34.80M
YoY Change 3862.5% -399.71% 34.36%
NET CHANGE
Cash From Operating Activities 44.20M -7.000M -23.40M
Cash From Investing Activities -22.90M -28.70M -18.10M
Cash From Financing Activities -31.70M -104.3M 34.80M
Net Change In Cash -10.40M -140.0M -6.300M
YoY Change 593.33% 2122.22% -57.72%
FREE CASH FLOW
Cash From Operating Activities $44.20M -$7.000M -$23.40M
Capital Expenditures $22.90M $28.70M $18.10M
Free Cash Flow $21.30M -$35.70M -$41.50M
YoY Change -765.63% -13.98% 4.01%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2024Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000717605
CY2024Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2024Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2024Q1 dei Amendment Flag
AmendmentFlag
false
CY2024Q1 us-gaap Environmental Loss Contingency Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#EmployeeRelatedLiabilitiesCurrent
CY2024Q1 us-gaap Environmental Loss Contingency Current Statement Of Financial Position Extensible Enumeration
EnvironmentalLossContingencyCurrentStatementOfFinancialPositionExtensibleEnumeration
http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2024Q1 dei Document Type
DocumentType
10-Q
CY2024Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2024Q1 dei Document Period End Date
DocumentPeriodEndDate
2024-03-31
CY2024Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2024Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2024Q1 dei Entity File Number
EntityFileNumber
1-8472
CY2024Q1 dei Entity Registrant Name
EntityRegistrantName
Hexcel Corporation
CY2024Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2024Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
94-1109521
CY2024Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
Two Stamford Plaza
CY2024Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
281 Tresser Boulevard
CY2024Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Stamford
CY2024Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
CT
CY2024Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
06901-3238
CY2024Q1 dei City Area Code
CityAreaCode
(203)
CY2024Q1 dei Local Phone Number
LocalPhoneNumber
969-0666
CY2024Q1 dei Security12b Title
Security12bTitle
Common Stock, par value $0.01
CY2024Q1 dei Trading Symbol
TradingSymbol
HXL
CY2024Q1 dei Security Exchange Name
SecurityExchangeName
NYSE
CY2024Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2024Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2024Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2024Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2024Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2024Q1 dei Entity Shell Company
EntityShellCompany
false
CY2024Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
83114360
CY2024Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
85900000
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
227000000
CY2024Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
271000000
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
234700000
CY2024Q1 us-gaap Inventory Net
InventoryNet
353800000
CY2023Q4 us-gaap Inventory Net
InventoryNet
334400000
CY2024Q1 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
31200000
CY2023Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
25100000
CY2024Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
47800000
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
43000000
CY2024Q1 us-gaap Assets Current
AssetsCurrent
789700000
CY2023Q4 us-gaap Assets Current
AssetsCurrent
864200000
CY2024Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3194800000
CY2023Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3195500000
CY2024Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1536600000
CY2023Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
1516800000
CY2024Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1658200000
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1678700000
CY2024Q1 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
248700000
CY2023Q4 us-gaap Intangible Assets Net Including Goodwill
IntangibleAssetsNetIncludingGoodwill
251300000
CY2024Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
5000000
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
5000000
CY2024Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
119600000
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
119300000
CY2024Q1 us-gaap Assets
Assets
2821200000
CY2023Q4 us-gaap Assets
Assets
2918500000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
100000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
100000
CY2024Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
128100000
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
159100000
CY2024Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
67300000
CY2023Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
75700000
CY2024Q1 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
4500000
CY2023Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
6000000
CY2024Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
88600000
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
75000000
CY2024Q1 us-gaap Liabilities Current
LiabilitiesCurrent
288600000
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
315900000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
714600000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
699400000
CY2024Q1 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
44300000
CY2023Q4 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
42600000
CY2024Q1 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
108400000
CY2023Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
110600000
CY2024Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33200000
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
33500000
CY2024Q1 us-gaap Liabilities
Liabilities
1189100000
CY2023Q4 us-gaap Liabilities
Liabilities
1202000000
CY2024Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000
CY2024Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
111300000
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
110800000
CY2024Q1 us-gaap Common Stock Value
CommonStockValue
1100000
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1100000
CY2024Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
954600000
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
936800000
CY2024Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2192600000
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2168700000
CY2024Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-89000000
CY2023Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-74100000
CY2024Q1 hxl Stockholders Equity Including Treasury Stock Value
StockholdersEquityIncludingTreasuryStockValue
3059300000
CY2023Q4 hxl Stockholders Equity Including Treasury Stock Value
StockholdersEquityIncludingTreasuryStockValue
3032500000
CY2024Q1 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
28200000
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
26700000
CY2024Q1 us-gaap Treasury Stock Value
TreasuryStockValue
1427200000
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1316000000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1632100000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1716500000
CY2024Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2821200000
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2918500000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
472300000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
457700000
CY2024Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
354100000
CY2023Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
330000000
CY2024Q1 us-gaap Gross Profit
GrossProfit
118200000
CY2023Q1 us-gaap Gross Profit
GrossProfit
127700000
CY2024Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
49000000
CY2023Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
50800000
CY2024Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15100000
CY2023Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
13900000
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1200000
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-200000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
52900000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
62800000
CY2024Q1 us-gaap Interest Expense
InterestExpense
6500000
CY2023Q1 us-gaap Interest Expense
InterestExpense
9400000
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
46400000
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
53400000
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
9900000
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
11700000
CY2024Q1 hxl Income Loss From Continuing Operations Before Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeLossFromEquityMethodInvestments
36500000
CY2023Q1 hxl Income Loss From Continuing Operations Before Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeLossFromEquityMethodInvestments
41700000
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
0
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1000000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36500000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
42700000
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.44
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.5
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.43
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.5
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83900000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84600000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84800000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85500000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36500000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
42700000
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-10400000
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
12000000
CY2024Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
100000
CY2023Q1 us-gaap Other Comprehensive Income Defined Benefit Plans Adjustment Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent
0
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
-4400000
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax Parent
OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTaxParent
10300000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14900000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
22300000
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
21600000
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
65000000
CY2024Q1 us-gaap Profit Loss
ProfitLoss
36500000
CY2023Q1 us-gaap Profit Loss
ProfitLoss
42700000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31000000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30700000
CY2024Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
100000
CY2023Q1 us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
100000
CY2024Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-700000
CY2023Q1 us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-2100000
CY2024Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
0
CY2023Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
1000000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
13100000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12900000
CY2024Q1 hxl Merger And Restructuring Expenses Net Of Payments
MergerAndRestructuringExpensesNetOfPayments
700000
CY2023Q1 hxl Merger And Restructuring Expenses Net Of Payments
MergerAndRestructuringExpensesNetOfPayments
-2100000
CY2024Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
0
CY2023Q1 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
-1700000
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
37500000
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
40500000
CY2024Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23000000
CY2023Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
32600000
CY2024Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
10000000
CY2023Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-100000
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-14000000
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-31000000
CY2024Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
3200000
CY2023Q1 us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
2300000
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-7000000
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-23400000
CY2024Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
28700000
CY2023Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
18100000
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-28700000
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-18100000
CY2024Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
15000000
CY2023Q1 us-gaap Proceeds From Long Term Lines Of Credit
ProceedsFromLongTermLinesOfCredit
65000000
CY2024Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
0
CY2023Q1 us-gaap Repayments Of Unsecured Debt
RepaymentsOfUnsecuredDebt
20000000
CY2024Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
100700000
CY2023Q1 us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0
CY2024Q1 hxl Repayment Of Finance Lease Obligation And Other Debt Net
RepaymentOfFinanceLeaseObligationAndOtherDebtNet
100000
CY2023Q1 hxl Repayment Of Finance Lease Obligation And Other Debt Net
RepaymentOfFinanceLeaseObligationAndOtherDebtNet
100000
CY2024Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
12600000
CY2023Q1 us-gaap Payments Of Dividends Common Stock
PaymentsOfDividendsCommonStock
10500000
CY2024Q1 hxl Proceeds From Payments To Stock Plans
ProceedsFromPaymentsToStockPlans
-5900000
CY2023Q1 hxl Proceeds From Payments To Stock Plans
ProceedsFromPaymentsToStockPlans
400000
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-104300000
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
34800000
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-1100000
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
400000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-141100000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-6300000
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
227000000
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
112000000
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
85900000
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
105700000
CY2024Q1 hxl Net Impact Of Capital Expenditure Payments And Accrued Payables
NetImpactOfCapitalExpenditurePaymentsAndAccruedPayables
18600000
CY2023Q1 hxl Net Impact Of Capital Expenditure Payments And Accrued Payables
NetImpactOfCapitalExpenditurePaymentsAndAccruedPayables
16800000
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
1554200000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
42700000
CY2023Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.125
CY2023Q1 us-gaap Dividends Common Stock
DividendsCommonStock
10400000
CY2023Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
22300000
CY2023Q1 hxl Share Based Compensation Expense And Exercise Of Shares Including Treasury Stock Acquired For Tax Obligations
ShareBasedCompensationExpenseAndExerciseOfSharesIncludingTreasuryStockAcquiredForTaxObligations
13400000
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
1622200000
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1716500000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36500000
CY2024Q1 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.15
CY2024Q1 us-gaap Dividends Common Stock
DividendsCommonStock
12600000
CY2024Q1 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
100700000
CY2024Q1 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-14900000
CY2024Q1 hxl Share Based Compensation Expense And Exercise Of Shares Including Treasury Stock Acquired For Tax Obligations
ShareBasedCompensationExpenseAndExerciseOfSharesIncludingTreasuryStockAcquiredForTaxObligations
7300000
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
1632100000
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
36500000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
42700000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83900000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84600000
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.44
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Basic Share
IncomeLossFromContinuingOperationsPerBasicShare
0.5
CY2024Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
36500000
CY2023Q1 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
42700000
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
83900000
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
84600000
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
84800000
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
85500000
CY2024Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.43
CY2023Q1 us-gaap Income Loss From Continuing Operations Per Diluted Share
IncomeLossFromContinuingOperationsPerDilutedShare
0.5
CY2024Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
400000
CY2023Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
500000
CY2024Q1 hxl Federal Funds Rate Plus
FederalFundsRatePlus
0.005
CY2024Q1 hxl Sofr Rate Borrowings
SofrRateBorrowings
0.00125
CY2024Q1 us-gaap Debt Instrument Unused Borrowing Capacity Description
DebtInstrumentUnusedBorrowingCapacityDescription
Borrowings under the Facility bear interest for Secured Overnight Financing Rate ("SOFR") borrowings at (i) an Adjusted Term SOFR rate (subject to a 0.00% floor), where such “Adjusted Term SOFR” rate is equal to the Term SOFR rate for the applicable interest period plus 0.10%, plus the Applicable Margin or (ii) for base rate borrowings, the greatest of (a) the prime rate, (b) the federal funds rate plus 0.50% and (c) the Adjusted Term SOFR rate (subject to a 0.00% floor) for a one-month interest period plus 1.00%, in each case plus the Applicable Margin. The “Applicable Margin” initially was 1.125% for SOFR rate borrowings and 0.125% for base rate borrowings, and after September 30, 2023, can fluctuate, determined by reference to the more favorable to the Company of its (i) public debt rating and (ii) consolidated leverage ratio, as specified in the Credit Agreement. Up to $50 million of the Facility may be used for letters of credit. The Credit Agreement enables the Company, from time to time, to add term loans or to increase the revolving credit commitment in an aggregate amount not to exceed $500 million.
CY2024Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
155500000
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
131400000
CY2024Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
40500000
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
46000000
CY2024Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
157800000
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
157000000
CY2024Q1 us-gaap Inventory Net
InventoryNet
353800000
CY2023Q4 us-gaap Inventory Net
InventoryNet
334400000
CY2024Q1 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
700000
CY2024Q1 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
100000
CY2023Q4 us-gaap Finance Lease Liability Current
FinanceLeaseLiabilityCurrent
100000
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
100000
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
100000
CY2024Q1 hxl Finance Lease Obligations Noncurrent And Other Long Term Debt
FinanceLeaseObligationsNoncurrentAndOtherLongTermDebt
1600000
CY2023Q4 hxl Finance Lease Obligations Noncurrent And Other Long Term Debt
FinanceLeaseObligationsNoncurrentAndOtherLongTermDebt
1700000
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
714600000
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
699400000
CY2024Q1 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
714700000
CY2023Q4 us-gaap Debt And Capital Lease Obligations
DebtAndCapitalLeaseObligations
699500000
CY2024Q1 hxl Applicable Interest Period Plus
ApplicableInterestPeriodPlus
0.001
CY2024Q1 us-gaap Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months
600000
CY2024Q1 hxl Foreign Currency Cash Flow Hedge Gain Loss To Be Reclassified During Next12 Months Tax Amount
ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12MonthsTaxAmount
200000
CY2024Q1 hxl Number Of Counterparties That Are Highly Rated Financial Institutions Which Experienced Significant Downgrades
NumberOfCounterpartiesThatAreHighlyRatedFinancialInstitutionsWhichExperiencedSignificantDowngrades
0
CY2024Q1 us-gaap Revenue Performance Obligation Description Of Timing
RevenuePerformanceObligationDescriptionOfTiming
As our production cycle is typically nine months or less, it is expected that goods related to the revenue recognized over time will be shipped and billed within the next twelve months.
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
472300000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
457700000
CY2023Q4 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
25100000
CY2024Q1 hxl Change In Unbilled Revenue Earned Over Time
ChangeInUnbilledRevenueEarnedOverTime
6000000
CY2024Q1 us-gaap Contract With Customer Asset Net
ContractWithCustomerAssetNet
31100000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
472300000
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
472300000
CY2024Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-1200000
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
52900000
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
1900000
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31000000
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
13100000
CY2024Q1 hxl Net Impact Of Capital Expenditure Payments And Accrued Payables
NetImpactOfCapitalExpenditurePaymentsAndAccruedPayables
18600000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
457700000
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
457700000
CY2023Q1 us-gaap Other Operating Income Expense Net
OtherOperatingIncomeExpenseNet
-200000
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
62800000
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
30700000
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12900000
CY2023Q1 hxl Net Impact Of Capital Expenditure Payments And Accrued Payables
NetImpactOfCapitalExpenditurePaymentsAndAccruedPayables
16800000
CY2023Q4 hxl Operating Segment Including Goodwill And Intangible Assets
OperatingSegmentIncludingGoodwillAndIntangibleAssets
251300000
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1600000
CY2024Q1 hxl Goodwill And Intangible Assets Currency Translation And Other Adjustments
GoodwillAndIntangibleAssetsCurrencyTranslationAndOtherAdjustments
-1000000
CY2024Q1 hxl Operating Segment Including Goodwill And Intangible Assets
OperatingSegmentIncludingGoodwillAndIntangibleAssets
248700000
CY2024Q1 us-gaap Goodwill
Goodwill
187800000
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
60900000
CY2017Q3 hxl Number Of Identified Non Governmental Potentially Responsible Parties
NumberOfIdentifiedNonGovernmentalPotentiallyResponsibleParties
120
CY2024Q1 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
600000
CY2023Q4 us-gaap Accrual For Environmental Loss Contingencies
AccrualForEnvironmentalLossContingencies
700000
CY2023Q4 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
2800000
CY2024Q1 hxl Standard Product Warranty Expense Benefit
StandardProductWarrantyExpenseBenefit
800000
CY2024Q1 hxl Standard Product Warranty Accrual Period Decrease Excluding Warranties Issued
StandardProductWarrantyAccrualPeriodDecreaseExcludingWarrantiesIssued
300000
CY2024Q1 us-gaap Standard Product Warranty Accrual
StandardProductWarrantyAccrual
3300000
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
1200000
CY2023Q4 us-gaap Restructuring Reserve
RestructuringReserve
1200000
CY2024Q1 us-gaap Restructuring Charges
RestructuringCharges
1200000
CY2024Q1 us-gaap Restructuring Reserve Translation Adjustment
RestructuringReserveTranslationAdjustment
100000
CY2024Q1 us-gaap Payments For Restructuring
PaymentsForRestructuring
400000
CY2024Q1 hxl Restructuring Reserve Settled And Received Without Cash
RestructuringReserveSettledAndReceivedWithoutCash
0
CY2024Q1 us-gaap Restructuring Reserve
RestructuringReserve
1900000

Files In Submission

Name View Source Status
0000950170-24-046457-index-headers.html Edgar Link pending
0000950170-24-046457-index.html Edgar Link pending
0000950170-24-046457.txt Edgar Link pending
0000950170-24-046457-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
hxl-20240331.htm Edgar Link pending
hxl-20240331.xsd Edgar Link pending
hxl-ex10_1.htm Edgar Link pending
hxl-ex10_2.htm Edgar Link pending
hxl-ex10_3.htm Edgar Link pending
hxl-ex31_1.htm Edgar Link pending
hxl-ex31_2.htm Edgar Link pending
hxl-ex32.htm Edgar Link pending
img130925042_0.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
hxl-20240331_htm.xml Edgar Link completed
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending